ENDV (Endonovo Therapeutics) Days Payable : 0.00 (As of Sep. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Endonovo Therapeutics Days Payable?

Endonovo Therapeutics's average Accounts Payable for the three months ended in Sep. 2024 was $1.13 Mil. Endonovo Therapeutics's Cost of Goods Sold for the three months ended in Sep. 2024 was $0.00 Mil.

The historical rank and industry rank for Endonovo Therapeutics's Days Payable or its related term are showing as below:

ENDV' s Days Payable Range Over the Past 10 Years
Min: 1483.55 Med: 10380.04 Max: 146060.83
Current: 146060.83

During the past 13 years, Endonovo Therapeutics's highest Days Payable was 146060.83. The lowest was 1483.55. And the median was 10380.04.

ENDV's Days Payable is ranked better than
99.15% of 703 companies
in the Biotechnology industry
Industry Median: 122.89 vs ENDV: 146060.83

Endonovo Therapeutics's Days Payable stayed the same from Jun. 2023 (0.00) to Sep. 2024 (0.00). stayed the same

Endonovo Therapeutics Days Payable Historical Data

The historical data trend for Endonovo Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endonovo Therapeutics Days Payable Chart

Endonovo Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

1,483.55

3,594.70

16,534.50

28,141.50

44,872.19

Endonovo Therapeutics Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Jun24	Sep24
Days Payable	Get a 7-Day Free Trial															-	132,723.13	38,674.79	-	-

Competitive Comparison of Endonovo Therapeutics's Days Payable

For the Biotechnology subindustry, Endonovo Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Endonovo Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Endonovo Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Endonovo Therapeutics's Days Payable falls into.

Save Embed

;

Save Embed

;

Endonovo Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Endonovo Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.884	+	1.083)	/	2 )	/	0.008	*	365
=	0.9835					/	0.008	*	365
=	44,872.19

Endonovo Therapeutics's Days Payable for the quarter that ended in Sep. 2024 is calculated as:

	Days Payable (Q: Sep. 2024 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2024 )	+	Accounts Payable (Q: Sep. 2024 ))	/	count )	/	Cost of Goods Sold (Q: Sep. 2024 )	*	Days in Period
=	( (1.129	+	1.13)	/	2 )	/	0	*	365 / 4
=	1.1295					/	0	*	365 / 4
=	N/A

Endonovo Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Endonovo Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Endonovo Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Endonovo Therapeutics Inc (OTCPK:ENDV) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367

Website

https://www.endonovo.com

Endonovo Therapeutics Inc is an USA-based biotechnology company that focuses on the business of biomedical research and development, particularly in regenerative medicine, which has included the development of its proprietary square waveform device. It is engaged in developing the Immunotronics platform which is non-implantable, a non-invasive medical device to target inflammatory conditions in vital organs; and the Cytotronics platform which uses Time-Varying Electromagnetic Fields technology for the creation of cell-based therapies. The company generates its revenue through its technology licensing and commercialization activities.

Executives

Alan Brian Collier	director, 10 percent owner, officer: CEO	6320 CANOGA AVENUE, 15TH FLOOR, WOODLAND HILLS CA 91367
Michael Scott Mann	10 percent owner, officer: President	6320 CANOGA AVENUE, WOODLAND HILLS CA 91367